Has the new TNM classification for colorectal cancer improved care?

Nature Reviews Clinical Oncology

Volumn 9, Issue 2, 2012, Pages 119-123

  Nagtegaal, Iris D ^a   Quirke, Phil ^b   Schmoll, Hans Joachim ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LUNG CANCER; PATIENT CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CARCINOMA; REVIEW;

COLORECTAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 84856596656     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.157     Document Type: Review

References (37)

1. Nagtegaal, I. D. & Quirke, P. Revised staging: is it really better, or do we not know? J. Clin. Oncol. 28, e397-e398 (2010).
2. Sobin, L. H., Gospodarowicz, M. K. & Wittekind, C. (Eds). TNM Classification of Malignant Tumours 7th edn (Wiley-Blackwell, New York, 2009).
3. Benson, A. B. 3rd et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J. Clin. Oncol. 22, 3408-3419 (2004).
4. Pollheimer, M. J. et al. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int. J. Colorectal Dis. 25, 187-196 (2010).
5. Sobin, L. H. & Wittekind, C. (Eds). TNM Classification of Malignant Tumours 5th edn (Wiley-Blackwell, New York, 1997).
6. Sobin, L. H. TNM, sixth edition: new developments in general concepts and rules. Semin. Surg. Oncol. 21, 19-22 (2003). (Pubitemid 37127470)
7. Sobin, L. H. & Wittekind, C. (Eds). TNM Classification of Malignant Tumours 6th edn (Wiley-Blackwell, New York, 2002).
8. Wnsch, K. et al. Shape is not associated with the origin of pericolonic tumor deposits. Am. J. Clin. Pathol. 133, 388-394 (2010).
9. Nagtegaal, I. D. et al. Lymph nodes, tumor deposits and TNM: are we getting better? J. Clin. Oncol. 29, 2487-2492 (2011).
10. Quirke, P. et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 8, 651-657 (2007). (Pubitemid 46995637)
11. Quirke, P. et al. Evidence-based medicine: the time has come to set standards for staging. J. Pathol. 221, 357-360 (2010).
12. Gunderson, L. L., Jessup, J. M., Sargent, D. J., Greene, F. L. & Stewart, A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J. Clin. Oncol. 28, 256-263 (2010).
13. Gunderson, L. L., Jessup, J. M., Sargent, D. J., Greene, F. L. & Stewart, A. K. Revised TN categorization for colon cancer based on national survival outcomes data. J. Clin. Oncol. 28, 264-271 (2010).
14. Sobin, L. H. et al. Evidence-based medicine: the time has come to set standards for staging. Is a radical overhaul really needed? J. Pathol. 221, 361-362 (2010).
15. Fleming, F. J., Phlman, L. & Monson, J. R. Neoadjuvant therapy in rectal cancer. Dis. Colon Rectum 54, 901-912 (2011).
16. Schmoll, H.-J. et al. The ESMO consensus guidelines for the management of colon and rectal cancer: personalized decision making. Ann. Oncol. (in press).
17. Elferink, M. A. et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006 Eur. J. Cancer 46, 1421-1429 (2010).
18. Valentini, V. et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother. Oncol. 92, 148-163 (2009).
19. Marijnen, C. A. et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J. Clin. Oncol. 19, 1976-1984 (2001). (Pubitemid 32702542)
20. Astler, V. B. & Coller, F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 139, 846-852 (1954).
21. Wittekind, C., Greene, F., Hutter, R. V. P., Sobin, L. H. & Henson, D. E. (Eds). TNM Supplement: a Commentary on Uniform Use 3rd edn (Wiley-Blackwell, New York, 2003).
22. Nagtegaal, I. D. & Marijnen, C. A. M. The future of TNM in rectal cancer: the era of neoadjuvant therapy. Cur. Colorectal Cancer Rep. 4, 147-154 (2008).
23. Vuong, T. et al. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Dis. Colon Rectum 45, 1486-1493 (2002).
24. Allen, D. C., Fon, L. J., McAleer, J. J. & Irwin, S. T. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy. Ulster Med. J. 68, 17-21 (1999). (Pubitemid 29264286)
25. Stein, D. E. et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis. Colon Rectum 46, 448-453 (2003). (Pubitemid 36428037)
26. Chau, I. et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol. 24, 668-674 (2006). (Pubitemid 46630432)
27. Gosens, M. J. et al. Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours. Ann. Oncol. 19, 2026-2032 (2008).
28. Nagtegaal, I. D. & Quirke, P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology 51, 141-149 (2007). (Pubitemid 47083979)
29. Song, J. S. et al. Is the N1c category of the new American Joint Committee on Cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy? Cancer 117, 3917-3924 (2011).
30. Wittekind, C., Henson, D. E., Hutter, R. V. P. & Sobin, L. H. (Eds). TNM supplement: a commentary on uniform use (Wiley-Blackwell, New York, 2001).
31. Giroux, D. J. et al. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J. Thorac. Oncol. 4, 679-683 (2009).
32. Rami-Porta, R., Bolejack, V. & Goldstraw, P. The new tumor, node, and metastasis staging system. Semin. Respir. Crit Care Med. 32, 44-51 (2011).
33. Rusch, V. W. et al. The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J. Thorac. Cardiovasc. Surg. 139, 819-821 (2010).
34. Vallières, E. et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 4, 1049-1059 (2009).
35. Segnan, N., Patnick, J. & von Karsa, L. (Eds). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis 1st edn (Publication Office of the European Union, Luxembourg, 2010).
36. Allegra, C. J. et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J. Clin. Oncol. 29, 11-16 (2011).
37. Leeds Institute of Molecular Medicine. Virtual Pathology at the University of Leeds [online] www.virtualpathology.leeds.ac.uk (2011).